Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Institute of Biological Products)

四价流感病毒裂解疫苗（长春生物制品研究所）

Report date: 2026/05/13 20:02:10

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Institute of Biological Products)
Drug Alias NameTetravalent split influenza vaccine (Changchun Institute of Biological Products)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanCommon Cold
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2020/03/11
Country/TerritoryMacauMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A